Transplantation Surveys: Managing Antibody-Mediated Rejection and HLA Sensitisation

ESOT is delighted to announce the launch of two new surveys which will be used to analyse the physician’s approach in managing two key transplantation practices.

One survey will investigate the physician’s approach to managing chronic Antibody-Mediated Rejection. The project, in collaboration with CSL Behring, will deliver an in-depth overview of the management of Antibody-Mediated Rejection across Europe, gaining insight into diagnosis, monitoring and treatments.

The second survey, also in collaboration with CSL Behring, will look to analyse the management of HLA sensitisation for kidney transplant recipients.

The two surveys will help investigate gaps and opportunities within the two areas and have been carefully put together by an expert panel. The findings will be used to inform consensus documents, educational workshops and, finally, a white paper to be published in Transplant International.

ESOT and CSL Behring welcomes input into this initiative from the transplantation community by completing both surveys.

We thank you for your valuable input!